Sarah Bétrian
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 11
-
- Endometrial and Cervical Cancer Treatments 10
-
- Cancer Immunotherapy and Biomarkers 5
- PARP inhibition in cancer therapy 3
-
- Intraperitoneal and Appendiceal Malignancies 7
- Bladder and Urothelial Cancer Treatments 2
-
- Multiple Myeloma Research and Treatments 2
-
- Cervical Cancer and HPV Research 2
- Co-authors
- Carlos Gomez‐RocaMartina Aida ÁngelesÉmmanuelle VigariosV. SibaudJean Pierre DelordAlejandra MartínezJean‐Pierre DelordAlicia Hernández
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Annals of Oncology (2 papers)
In The Last Decade
Sarah Bétrian
22 papers receiving 172 citations
Peers
Comparison fields: 5 of 42
- Reproductive Medicine 55
- Obstetrics and Gynecology 28
- Dermatology 21
- Oncology 59
- Surgery 53
Countries citing papers authored by Sarah Bétrian
This map shows the geographic impact of Sarah Bétrian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Bétrian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Bétrian more than expected).
Fields of papers citing papers by Sarah Bétrian
This network shows the impact of papers produced by Sarah Bétrian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Bétrian. The network helps show where Sarah Bétrian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah Bétrian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 0 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 10 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 5 | |
| 15 | 2021 | 1 | |
| 16 | 2020 | 11 | |
| 17 | 2018 | 18 | |
| 18 | 2017 | 15 | |
| 19 | 2015 | 14 | |
| 20 | 2013 | 7 |
About Sarah Bétrian
Sarah Bétrian is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology, having authored 25 papers that have together received 173 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (10 papers), Intraperitoneal and Appendiceal Malignancies (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), PARP inhibition in cancer therapy (3 papers), Multiple Myeloma Research and Treatments (2 papers), Cervical Cancer and HPV Research (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Reproductive Medicine (55 citations), Obstetrics and Gynecology (28 citations) and Dermatology (21 citations). Sarah Bétrian has collaborated with scholars based in France, Spain and Poland. Frequent co-authors include Carlos Gomez‐Roca, Martina Aida Ángeles, Émmanuelle Vigarios, V. Sibaud, Jean Pierre Delord, Alejandra Martínez, Jean‐Pierre Delord, Alicia Hernández, Isabelle Luquet and Carlos Martínez-Gómez. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.